Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medifast (MED) Interest & Investment Income (2016 - 2025)

Medifast's Interest & Investment Income history spans 16 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 49.0% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $5.5 million, up 14.8%, while the annual FY2025 figure was $5.5 million, 14.82% up from the prior year.
  • Interest & Investment Income reached $1.4 million in Q4 2025 per MED's latest filing, roughly flat from $1.4 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.4 million in Q3 2025 to a low of -$261000.0 in Q3 2022.
  • Average Interest & Investment Income over 5 years is $593900.0, with a median of $707500.0 recorded in 2023.
  • Peak YoY movement for Interest & Investment Income: crashed 513.04% in 2022, then soared 775.69% in 2024.
  • A 5-year view of Interest & Investment Income shows it stood at -$93000.0 in 2021, then plummeted by 95.7% to -$182000.0 in 2022, then skyrocketed by 746.15% to $1.2 million in 2023, then dropped by 18.96% to $953000.0 in 2024, then surged by 49.0% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Interest & Investment Income are $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $1.4 million (Q2 2025).